Y. Uchiyama

Identification of patients with Graves’ disease who benefit from high-dose radioactive iodine therapy

K. Hirata, T. Toyonaga, Shiro Watanabe, 2022, Annals of Nuclear Medicine.

Effects of Repeated 131I-Meta-Iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activity in Patients with Metastatic Neuroendocrine Tumors

Yoichi M. Ito, T. Shiga, N. Tamaki, 2020, The Journal of Nuclear Medicine.

Prognostic value of [^18F]FDG-PET prior to [^131I]MIBG treatment for pheochromocytoma and paraganglioma (PPGL)

K. Hirata, N. Shinohara, T. Abe, 2022, Annals of Nuclear Medicine.

Development and validation of a prediction model based on the organ-based metabolic tumor volume on FDG-PET in patients with differentiated thyroid carcinoma

Yoichi M. Ito, T. Shiga, K. Hirata, 2021, Annals of Nuclear Medicine.

Lung uptake on I-131 therapy and short-term outcome in patients with lung metastasis from differentiated thyroid cancer

T. Shiga, N. Tamaki, Kentaro Kobayashi, 2013, Annals of Nuclear Medicine.

The utility of FDG-PET for detecting multiple primary cancers in hypopharyngeal cancer patients

S. Kurata, H. Kaida, M. Ishibashi, 2009, Nuklearmedizin.

FDG PET Performed at Thyroid Remnant Ablation Has a Higher Predictive Value for Long-Term Survival of High-Risk Patients With Well-Differentiated Thyroid Cancer Than Radioiodine Uptake

Yoichi M. Ito, T. Shiga, N. Tamaki, 2015, Clinical nuclear medicine.

Herpes zoster infection mimicking pelvic lymph node metastasis on FDG-PET/CT in a patient with cervical cancer.

F. Kato, K. Hirata, K. Kudo, 2021, Asia Oceania journal of nuclear medicine & biology.